DB Schenker secures GDP certification for more than 150 stations

DB Schenker announced the certifications in accordance with Good Distribution Practice (GDP) standards for 157 stations.

The most important markets for the global trade of medical goods, spanning the Americas, Europe and Asia, are now covered within the DB Schenker life+ product portfolio, according to the press release from DB Schenker. Stations here refer to operational units at DB Schenker.

DB Schenker can now cover 80 percent of the world's healthcare flows with their recent certificates, making it one of the world’s largest GDP-compliant logistics networks. DB Schenker can now even better meet the evolving needs of the global pharmaceutical industry.

Veronique Dameme, Head of Global Vertical Market Healthcare, DB Schenker says: “At the end of every healthcare supply chain there is a patient. That’s why we ensure that medical products are stored and distributed in accordance with the highest standards. The successful GDP certification of our facilities marks a significant milestone on our roadmap and shows our ongoing pursuit of excellence in pharmaceutical logistics.”

With GDP, DB Schenker follows a quality guideline that ensures that the integrity and quality of pharmaceutical products are maintained throughout the entire supply chain process. DB Schenker’s internal Global Healthcare Quality Management System addresses the GDP for medicinal products for human and veterinary use and related active substances set out by the European Union (EU) and the World Health Organisation (WHO). DB Schenker ensures these requirements are complied with through the internal Directive Healthcare Quality Management, which forms the basis of DB Schenker life+, the release added.

Within the next 12 months, the global logistics service provider plans to certify over 180 of its stations to be able to organize and manage GDP-compliant logistics.

Also Read:DB Schenker keeps A-SAFE's operations on track for new facility